AlphAIAlphAI — Financial news for AI agents
SEC EDGARAUG 101 min read$ISRG

LOEB GARY sold $152K of ISRG

LOEB GARY (EVP & Chief Legal and Complian) sold 400 shares of INTUITIVE SURGICAL INC (ISRG) at $379.00 ($0.15M total) on 2026-08-10 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · LOEB GARY
Published Aug 10, 2026, 9:55 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 10, 2026, 9:56 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$ISRG
Neutral
high confidence
Mentioned
$ISRG
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ISRGNeutralLow
01

Why it matters

The newest fact is the specific sale: 400 shares at $379 on 2026-08-10, with holdings after transaction of 5,320 shares, under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note insider selling, but the 10b5-1 structure generally makes this more of a compliance disclosure than a fundamental catalyst.

03

What to watch

The filing does not indicate intent beyond the plan, and the share count and dollar value are not described as unusually large relative to typical insider activity, limiting tradable inference.

Relevance 3/10Novelty 3/10Timing: filed on 2026-08-10, after-hours/late session disclosure

Background

The article is a SEC Form 4 insider transaction disclosure for Intuitive Surgical (ISRG).

Company-level read

Ticker impact

$ISRGNeutralHigh confidence
Context

Form 4 shows Loeb Gary, ISRG EVP and Chief Legal and Compliance, sold 400 shares at $379 on 2026-08-10 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move driven by this filing alone.

Evidence & confidence

The disclosure is an insider sale (not a buy), but it is explicitly tied to a pre-arranged 10b5-1 plan, which typically reduces interpretive value versus discretionary selling.

Market effects

Sector

No clear sector read-through; this is company-specific insider transaction data.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Even with a 10b5-1 plan, repeated insider selling can coincide with executives de-risking ahead of known personal liquidity needs, which some traders may still treat as a mild negative sentiment input.

Key entities

  • issuer
    ISRG

    Intuitive Surgical, the company whose insider transaction is disclosed.

  • insider
    LOEB GARY

    EVP and Chief Legal and Compliance officer who executed the sale.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ISRG insider trading history →

Related articles

SEP 30
$ISRGHighAI 8/10

Intuitive receives CE mark for da Vinci 5 cardiac procedures

Intuitive Surgical (ISRG) received CE mark approval for its da Vinci 5 system in cardiac procedures, including coronary artery bypasses and thoracoscopic cardiotomy. The company aims to expand its robotic-assisted cardiac surgery offerings in Europe, with a dedicated team and partnerships with select centers. ISRG previously received FDA clearance for cardiac use in January.

massdevice.com2 min
SEP 29
$ISRGHighAI 8/10

Intuitive Surgical Gains CE Mark for Cardiac Robotics

Intuitive Surgical received CE mark approval for its da Vinci surgical robot to perform cardiac procedures in adults, including minimally invasive coronary artery bypass. This approval allows Intuitive to compete with rivals Medtronic and Johnson & Johnson in the surgical robotics space. The company aims to expand its cardiac surgery offerings globally, following FDA clearance for cardiovascular procedures in January.

mddionline.com3 min
SEP 15
$ISRGHighAI 8/10

Intuitive receives CE mark for transvaginal use of da Vinci SP system

Intuitive Surgical (ISRG) received CE mark approval for its da Vinci SP system for transvaginal gynecological procedures in Europe, expanding its use in women's health. The system, already approved for other surgeries, allows single-incision operations, potentially improving recovery and outcomes. It is also approved in the US, Japan, and Korea.

yahoo.com2 min
SEP 14
$ISRGHigh

Intuitive announces expanded indication for da Vinci SP in Europe

Intuitive (ISRG) received CE mark approval for transvaginal gynecologic procedures using the da Vinci SP system in Europe, expanding its applications. The approval allows for less invasive options and potentially better recovery experiences. The system is already approved in the US, Japan, and Korea for various procedures.

prnewswire.com2 min